Actively Recruiting
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Led by Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · Updated on 2026-03-18
187
Participants Needed
19
Research Sites
327 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to assess BMS-986453 in participants with relapsed and/or refractory multiple myeloma (RRMM).
CONDITIONS
Official Title
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of multiple myeloma with relapsed and/or refractory disease
- Confirmed progressive disease on or within 12 months of last anti-myeloma treatment
- Previous antimyeloma therapy including a proteasome inhibitor and an immunomodulatory agent
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
- Adequate organ function
You will not qualify if you...
- Known active or history of central nervous system involvement of multiple myeloma
- Active or history of plasma cell leukemia, Waldenstrom's macroglobulinemia, POEMS syndrome, or clinically significant amyloidosis
- History or presence of significant CNS conditions such as seizure disorder, aphasia, stroke, severe brain injury, dementia, Parkinson's disease, cerebellar disease, or active psychosis
- Other protocol-defined inclusion/exclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 19 locations
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294
Actively Recruiting
2
City of Hope Comprehensive Cancer Center
Duarte, California, United States, 91010
Actively Recruiting
3
UCSF Helen Diller Medical Center at Parnassus Heights
San Francisco, California, United States, 94143
Actively Recruiting
4
Stanford University Medical Center
Stanford, California, United States, 94305
Actively Recruiting
5
Colorado Blood Cancer Institute
Denver, Colorado, United States, 80218
Actively Recruiting
6
Yale Cancer Center
New Haven, Connecticut, United States, 06520
Actively Recruiting
7
Moffitt Cancer Center
Tampa, Florida, United States, 33612
Actively Recruiting
8
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
Actively Recruiting
9
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
Actively Recruiting
10
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Actively Recruiting
11
Local Institution - 0008
Nashville, Tennessee, United States, 37203
Not Yet Recruiting
12
Tennessee Oncology
Nashville, Tennessee, United States, 37203
Actively Recruiting
13
Swedish Medical Center
Seattle, Washington, United States, 98104
Actively Recruiting
14
Hôpital Saint-Louis
Paris, France, 75010
Actively Recruiting
15
Universitaetsklinikum Koeln
Cologne, Germany, 50937
Actively Recruiting
16
Universitaetsklinikum Heidelberg
Heidelberg, Germany, D-69120
Actively Recruiting
17
Universitaetsklinikum Wuerzburg
Würzburg, Germany, 97080
Actively Recruiting
18
Clinica Universidad de Navarra
Pamplona, Navarre, Spain, 31008
Actively Recruiting
19
Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca
Salamanca, Spain, 37007
Actively Recruiting
Research Team
B
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
CONTACT
F
First line of the email MUST contain NCT # and Site #.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here